However, treatment with the Wnt/β-catenin activator, Licl, reversed the protein expressions and restored TMZ resistance in the H19-silenced cells.31 Similarly, H19 has also been implicated to promote TMZ resistance in GBM through the NF-κβ pathway. The gene discussed is H19; the disease is glioblastoma.